DEFRA
DCTN1 (Dynactin Subunit 1) is a protein that in humans is encoded by the DCTN1 gene. It is a critical component of the dynactin complex, which is essential for various cellular processes, including intracellular transport, cell division, and maintenance of cell structure.
Structure[edit | edit source]
DCTN1 is a large protein that forms part of the dynactin complex, which is a multi-subunit assembly. The dynactin complex is composed of several subunits, including p150Glued (encoded by DCTN1), p50, p24, and others. The p150Glued subunit is responsible for binding to microtubules and interacting with the dynein motor protein, facilitating the transport of cellular cargo along microtubules.
Function[edit | edit source]
DCTN1 plays a crucial role in the function of the dynactin complex. It is involved in:
- Intracellular Transport: DCTN1, as part of the dynactin complex, assists in the transport of organelles, vesicles, and other cargoes along microtubules by linking them to the dynein motor protein.
- Cell Division: During mitosis, DCTN1 is involved in the proper alignment and segregation of chromosomes by stabilizing the mitotic spindle.
- Neuronal Function: In neurons, DCTN1 is important for the transport of neurotransmitter-containing vesicles and other materials necessary for synaptic function.
Clinical Significance[edit | edit source]
Mutations in the DCTN1 gene have been associated with several neurodegenerative disorders, including:
- Perry Syndrome: A rare, autosomal dominant disorder characterized by parkinsonism, weight loss, depression, and hypoventilation.
- Amyotrophic Lateral Sclerosis (ALS): Some mutations in DCTN1 have been linked to familial forms of ALS, a progressive neurodegenerative disease affecting motor neurons.
Research[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which DCTN1 mutations lead to neurodegenerative diseases. Studies are also exploring potential therapeutic strategies to target the dynactin complex in these conditions.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD